Can You Work in Pharma or Med Writing If Your Clinic Has IP Clauses?

15 min read
Clinician reviewing contract with pharmaceutical documents on desk

Here's the answer you're looking for: yes, you can usually work in pharma or medical writing even if your clinic contract has IP clauses, but only if you understand what your specific clause actually claims, and you structure your work to avoid stepping on it. Most clauses don't blanket-prohibit outside work. They claim ownership over specific things: clinic-related inventions, work product made using clinic resources, or patient-derived data. That's a much narrower band than "everything you ever write."

This article is educational purposes only and not legal advice. Contract language varies by jurisdiction and employer, figures vary, and the right path depends on your specific document. If you're staring at a clause you don't understand, consult a qualified professional.

The core issue isn't whether IP clauses block you from outside work, it's what those clauses actually claim ownership of. Most clinic contracts focus on inventions, written work created in your clinic role, and clinic-confidential information. They typically don't reach into writing you do independently, off-hours, using public sources, with no clinic resources.

What "IP clauses" commonly cover:

  • Work product and inventions made in the course of your clinic duties
  • Copyrights on materials you produce for the clinic
  • Confidentiality of clinic information, patients, and operations
  • Assignment of future IP that relates to the clinic's business
  • Non-compete or non-solicit restrictions on your next moves

The specifics determine your options. A clause saying "all inventions made during employment" is different from "all written work you ever produce." Read yours carefully, the difference matters enormously.

What "IP Clauses" Typically Mean in a Clinic Contract (And What They Usually Don't)

Let's break down what you're probably looking at.

IP assignment clauses claim ownership of inventions or copyrightable work you create as part of your clinic duties. If you're inventing a device while employed as a clinician-engineer, that clause probably owns it. If you're writing a literature review for a pharma company on a Saturday using public sources, that clause usually doesn't reach it.

"Work made for hire" language is a U.S. copyright concept that assigns ownership of certain works to the hiring party. It's narrower than people think, it covers specific categories like contributions to collective works, not everything you write on your own time.

Confidentiality and trade secret clauses prevent you from disclosing clinic information. These don't stop you from writing, they stop you from using their information in what you write.

Publication and pre-approval clauses require clinic sign-off before you publish. Annoying, but workable if you build the approval timeline into your project plan.

Non-compete and non-solicit are different beasts. Some states ban them for physicians outright. Others allow narrow versions. These can block lateral moves into competing practices, but rarely block pharma or medical writing roles.

The biggest misconception I see: clinicians assume their clinic owns "everything they ever write." That's almost never true. Most contracts have either explicit carve-outs for independent work or simply don't reach that far.

Your Real Risk Profile: 6 Questions to Answer Before You Apply

Run this checklist on your actual contract language before you send a single resume:

  1. Does it assign inventions or copyrights broadly? Look for "any work related to the clinic's business" or "all intellectual property created during employment." Broad is bad. Narrow is fine.
  2. Are you required to submit drafts for approval? Some clauses require you to disclose outside writing for review. That's a process issue, not a prohibition.
  3. Are there explicit carve-outs for independent work? Some contracts include language like "excluding work created entirely on personal time without use of clinic resources." If you have this, you're in much better shape.
  4. Does "related to" the clinic's business get defined broadly? If "clinic business" includes the therapeutic area you also write about, your topics might trigger clauses.
  5. What about data and templates? Clauses often claim ownership of clinical data you generate, internal protocols, and proprietary templates. Don't use these in outside work.
  6. Is there a non-compete or non-solicit? Check the scope: geography, time, and what's prohibited. Pharma roles rarely trigger non-competes unless you're moving into direct competition.

The work scenarios that most often trigger real conflicts:

  • Ghostwriting or summarizing data from clinic patients
  • Using datasets collected through your clinic role
  • Writing on topics tightly tied to your clinic's research program
  • Using clinic systems, software, or staff time for outside deliverables

If you're using none of those, you're usually fine.

Can Pharma/Med Writing Employers Work With You While You're Bound by Clinic IP? Yes, If You Set Boundaries

Pharma and medical writing employers are used to this. Their compliance teams handle clinician conflicts regularly, especially with academic medical centers and hospital-employed physicians. They'll want to know you have clarity on what you can and can't bring to the role.

How pharma/medical writing roles generally work:

  • Employment or contract with a defined scope and deliverables
  • NDA execution protecting proprietary pharma information
  • Internal templates and style guides for regulatory and clinical writing
  • Compliance standards (Sunshine Act, PhRMA Code, ICMJE authorship rules)
  • Audit trails of who wrote what, with what sources

The boundary strategies that work:

  • Work strictly within your assigned role scope, don't freelance on the side for the same employer without disclosure
  • Avoid clinic proprietary data, templates, or protocols in your pharma deliverables
  • Keep a clean separation between clinic projects and independent projects, different systems, different times, different documents
  • Document what materials come from where for every deliverable
Two parallel pathways showing clinic vs independent medical writing workflow

A Simple Decision Framework: Safe, Gray-Zone, or High-Risk?

Here's the flowchart. Run your situation through it.

What to do in each bucket:

Safe, proceed with disclosure to your pharma employer about your constraints. Keep a clean separation. Maintain an audit trail. You're good.

Gray, get written clarification from your clinic before you start. A side letter or email confirmation that your specific planned work doesn't fall under their IP claim is worth its weight in gold. Without it, you're guessing.

High-risk, consider renegotiating the clause, requesting an escrow arrangement where deliverables sit in neutral hands pending conflict resolution, or pivoting to an alternative career path that doesn't trigger the conflict. Don't just plow ahead and hope nobody notices.

What to Do With Your Clinic and Your Employer: Disclosures, Side Letters, and Audit Trails

Disclosure is a process, not a confession. Here's how to handle it cleanly.

With your clinic:

  • Request a written interpretation of how your clause applies to your planned outside work
  • Ask specifically whether medical writing for pharma on public-source topics counts
  • Get clarity on pre-approval timelines if your clause requires publication review
  • Document the conversation: who said what, when, in what form

With your pharma employer:

  • Inform HR/compliance that you have contractual IP and confidentiality obligations
  • Ask how they handle clinician conflicts, most have a process
  • Confirm in writing what materials you can and can't bring from your clinic
  • Keep copies of your signed NDAs, scope documents, and source attributions

What to disclose:

  • The existence of IP/confidentiality constraints
  • The scope of those constraints as you understand them
  • Your plan to keep clinic materials out of pharma deliverables

What NOT to over-disclose:

  • Patient identifiers or protected health information
  • Proprietary clinic protocols or templates
  • Internal clinic operations or strategic information
  • Anything your clinic NDA explicitly protects

An audit trail is your friend. For every deliverable, keep a simple log: what sources you used, where each section came from, who reviewed it, and how you separated clinic work from pharma work. If a conflict ever surfaces, that trail saves you.

Common Scenarios (Realistic Examples) and the Likely Outcome

Scenario 1: You write for pharma using only public literature.

You're a hospitalist who wants to take a contract medical writing role for a pharma company's HEOR team. Your work would involve summarizing published clinical trial data and writing review manuscripts on publicly available information.

Likely outcome: Workable. Your clinic clause almost certainly doesn't reach writing based on public literature, even if the topic overlaps with your clinic's therapeutic area. Disclose the planned role to your clinic, get a written confirmation that your independent writing using public sources isn't assigned, and proceed. Keep an audit trail of your sources.

Scenario 2: You use a dataset collected through your clinic.

You're a cardiologist who helped build a patient registry at your hospital. A pharma company wants to hire you to analyze that registry data and write a manuscript.

Likely outcome: Likely conflict. The dataset was collected under clinic auspices, often with IRB oversight and data use agreements. Your clinic's IP clause almost certainly claims ownership of that data. Using it for an outside employer without explicit permission risks a real fight. Either negotiate data-sharing terms with your clinic, get written consent from your pharma employer's compliance team, or pivot the project to use only public registry data.

Practical Negotiation/Compliance Tips (Without Killing Your Career Momentum)

You're allowed to negotiate. Clinics expect it, even if they don't love it. Here are tactics that work.

On the clinic side:

  • Ask for explicit carve-outs: independently created work, work done on personal time without clinic resources, and writing on topics outside the clinic's specific research focus
  • Request publication rights that allow you to publish without pre-approval after a reasonable review window (30 days is standard)
  • Ask for clarification on "related to clinic business", get it narrowed to specific programs or therapeutic areas
  • If your clinic refuses to negotiate, that's information. It tells you how restrictive the relationship really is.

On the job search side:

  • Apply to pharma/med writing roles while you're still employed, you don't need to disclose every clause detail upfront
  • Get a conditional offer before you disclose specifics to your clinic
  • Start work only after you have written clearance from your clinic
  • If clearance is slow, consider interim activities that don't trigger IP conflict: medical education content, advisory board work with narrow scopes, or freelance writing with strict source boundaries

The goal isn't to outmaneuver your clinic. It's to make sure you don't accidentally create a conflict that burns bridges. Most clinics are reasonable when approached early and professionally.

Explore Alternative Routes If IP Clauses Are Too Restrictive (Still in the Pharma/Med Writing Orbit)

If your clinic contract is genuinely too restrictive, broad IP assignment, no carve-outs, an aggressive pre-approval process, you still have options that stay in the pharma and medical writing universe.

  • Literature-based medical education writing: CME modules, clinical review articles, and educational content using only published sources
  • Advisory roles with narrow scope: Single-meeting consults on specific protocol questions, with no deliverable ownership
  • Freelance with strict boundaries: Platforms that match clinicians to writing projects where you can explicitly state your input constraints
  • Companies with mature compliance processes: Larger medical communications agencies and CROs have built-in frameworks for handling clinician conflicts

These aren't fallback options, they're risk-managed choices that let you build a pharma/med writing career without taking on conflict risk you can't manage.

Conclusion: Don't Assume You're Blocked, Verify, Document, and Move Forward

Your clinic's IP clauses probably don't block you from pharma or medical writing. They almost certainly constrain what you can use, clinic data, proprietary templates, patient-derived materials, but they rarely prohibit outside writing itself.

Here's your action plan:

  1. Pull out your clinic contract and read the actual IP language
  2. Run the 6-question risk checklist
  3. Walk through the decision tree
  4. Get written clarification from your clinic on your specific planned work
  5. Disclose constraints to your pharma employer's compliance team
  6. Maintain an audit trail of sources for every deliverable

The clinicians who get burned are the ones who assume they're fine without checking, or assume they're blocked without verifying. Do neither. Get the facts, document everything, and proceed.

Ready to look at your contract? Start with the IP assignment language, that's where the real risk lives.

01 My clinic contract says it owns "all work product" I create. Can I still do medical writing for a pharma company?

Possibly, but you need the exact wording. "All work product" sounds terrifying, but contract language rarely means what it literally says. Courts and clinic administrators typically interpret it as work product created in the scope of your clinic duties, not everything you ever write. If your clause broadly assigns ownership without carve-outs, treat this as a gray-to-high risk situation. Get written clarification or a side letter confirming that independently created medical writing using public literature isn't assigned to the clinic. Don't guess, get it in writing.

02 If I only use publicly available sources (no clinic patient data), is it still a problem?

Often it's workable. Using public literature typically reduces conflict with clinic data and IP issues. However, if your clinic clause is very broad, assigning IP for anything "related to" your clinic's business, you still need to confirm whether it covers the topic or just the inputs. Topic-based claims are rare and usually unenforceable; input-based claims are common and enforceable. Disclose your boundaries to your employer and document your sources. That's usually enough.

03 Does a confidentiality clause in my clinic contract prevent me from writing for pharma?

Confidentiality usually prevents disclosure of clinic confidential information, not medical writing itself. You can still write, as long as you don't reveal patient identifiers, internal clinic operations, or proprietary clinic information. Use an audit trail: what information you used, where it came from, and how you kept clinic content out of your deliverables. Confidentiality clauses are easier to navigate than IP assignment clauses because they're typically narrower.

04 Can I publish a paper or poster if my clinic requires "pre-approval" for publications?

You can often still publish, but you must comply with the pre-approval requirement. Request approval early and submit cleanly separated drafts that don't use clinic confidential data unless permitted. If the pre-approval process is vague, ask your clinic to specify timelines and what standards they'll use to approve. A reasonable clinic will give you a 30-day review window and clear approval criteria. An unreasonable one will give you vague delays and shifting demands, that's a signal to renegotiate or move on.

05 Should I tell pharma employers about my clinic IP clauses during the hiring process?

Yes, at least at the compliance level. Don't over-share patient or confidential details, but inform HR and legal that you have contractual IP, assignment, and confidentiality obligations. Ask how they handle conflicts. Many employers are accustomed to this and can structure onboarding, NDA language, input restrictions, source tracking, to keep you compliant. Hiding it until you're caught is the worst move. Disclosing it upfront signals professionalism and makes you a safer hire, not a riskier one.


Keep reading

View more